Search results for " Diabetes mellitus"

showing 10 items of 309 documents

High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies

2017

Erectile dysfunction may be common among men with diabetes, but its prevalence is still debated. We aimed to assess the relative prevalence of erectile dysfunction in diabetes searching major databases from inception to November 2016 for studies reporting erectile dysfunction in men with Type 1 and Type 2 diabetes mellitus. We conducted a meta-analysis of the prevalence [and 95% confidence intervals (95% CIs)] of erectile dysfunction in diabetes compared with healthy controls, calculating the relative odds ratios (ORs) and 95% CIs. A random effect model was applied. From 3747 initial hits, 145 studies were included representing 88 577 men (age: 55.8 ± 7.9 years). The prevalence of erectile …

Malemedicine.medical_specialtyMEN 40Endocrinology Diabetes and Metabolism030232 urology & nephrology030209 endocrinology & metabolismReviewInternal Medicine; Endocrinology Diabetes and Metabolism; EndocrinologyOddsMELLITUS03 medical and health sciences0302 clinical medicineEndocrinologyErectile DysfunctionRisk FactorsDiabetes mellitusInternal medicinePrevalenceJournal ArticleInternal MedicineHumansEPIDEMIOLOGYMedicineHigh prevalencebusiness.industryType 2 Diabetes MellitusPublication biasmedicine.disease69 YEARS OLDConfidence intervalDiabetes and MetabolismErectile dysfunctionEndocrinologyDiabetes Mellitus Type 2BIASMeta-analysisHypertensionbusinessSEXUAL DYSFUNCTIONDiabetic Medicine
researchProduct

Comparative Study of the Efficacy of Olmesartan/Amlodipine vs. Perindopril/Amlodipine in Peripheral and Central Blood Pressure Parameters After Misse…

2016

Background Central aortic blood pressure (CBP) and CBP-derived parameters are independent predictors of cardiovascular risk. Angiotensin II receptor blockers (ARBs) or angiotensin-converting enzyme inhibitors plus calcium channel blockers are the recommended first-line treatments in hypertensive diabetic patients; however, the effect in reducing CBP when a dose is skipped has not been established yet. The aim was to determine whether the fixed-dose combination of olmesartan/amlodipine (OLM/AML) provides equal efficacy and safety as the perindopril/AML (PER/AML) combination in reducing CBP, augmentation index (AIx), and pulse wave velocity (PWV) when a drug dose is missed. Methods In this no…

Malemedicine.medical_specialtyMissed DoseFixed-dose combinationUrologyTetrazolesolmesartanPulse Wave Analysisamlodipine030204 cardiovascular system & hematologyNO03 medical and health sciences0302 clinical medicinehemic and lymphatic diseasesInternal MedicinemedicinePerindoprilHumans030212 general & internal medicineAmlodipineamlodipine antihypertensive agents blood pressure diabetes mellitus olmesartan perindoprilPulse wave velocityAgedbusiness.industryImidazolesblood pressureMiddle Agedantihypertensive agentsBlood pressureDiabetes Mellitus Type 2Hypertensiondiabetes mellitusAortic pressureFemaleperindoprilOlmesartanbusinessmedicine.drugAmerican Journal of Hypertension
researchProduct

Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia

2018

Abstract Background Pneumonia causes more deaths than any other infectious disease, especially in older patients with multiple chronic diseases. Recent studies identified a low functional status as prognostic factor for mortality in elderly patients with pneumonia while contrasting data are available about the role of diabetes. The aim of this study was to evaluate the in-hospital, 3-month and 1-year mortality in elderly subjects affected by pneumonia enrolled in the RePoSi register. Methods We retrospectively analyzed the data collected on hospitalized elderly patients in the frame of the REPOSI project. We analyzed the socio-demographic, laboratory and clinical characteristics of subjects…

Malemedicine.medical_specialtyMultivariate analysisBarthel indexSocio-culturaleComorbidity030204 cardiovascular system & hematologyDiabeteSeverity of Illness IndexComorbidity; Diabetes; Disability; Elderly; Pneumonia; Aged; Aged 80 and over; Comorbidity; Diabetes Mellitus; Disabled Persons; Female; Geriatric Assessment; Hospitalization; Humans; Italy; Logistic Models; Male; Multivariate Analysis; Pneumonia; Retrospective Studies; Risk Factors; Severity of Illness Index03 medical and health sciences0302 clinical medicineElderlyRisk FactorsDiabetes mellitusInternal medicineSeverity of illnessmedicine80 and overDiabetes MellitusInternal MedicineHumansDisabled Persons030212 general & internal medicineGeriatric AssessmentAgedRetrospective StudiesAged 80 and overDisabilitybusiness.industrySettore MED/09 - MEDICINA INTERNADiabetesRetrospective cohort studyOdds ratioPneumoniamedicine.diseaseOldest oldComorbidityPneumonia; Elderly; Disability; Diabetes; ComorbidityHospitalizationLogistic ModelsItalyMultivariate AnalysisFemaleComorbidity Diabetes Disability Elderly Pneumoniabusiness
researchProduct

Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients

2006

Objective: To evaluate circulating serum ionized magnesium (i-Mg) concentrations in patients with type 2 diabetes mellitus, and to investigate its relationship with the components of the metabolic syndrome. Design: cross-sectional study. Setting: Outpatients' service for diabetic patients at the University Hospital of Messina, Italy. Subjects: 290 patients with type 2 diabetes mellitus. Measures of Outcome: Serum i-Mg was measured by ion selective electrode. Age, gender, body mass index (BMI), waist circumference, blood pressure, fasting glucose, HbA1c, HDL cholesterol, triglycerides, and urinary albumin excretion rate (UAER) were considered in the analyses. Patients with hypomagnesemia, de…

Malemedicine.medical_specialtyPlasma triglyceridesMedicine (miscellaneous)Type 2 diabetesplasma triglycerideHypomagnesemiaWaist–hip ratioDiabetes mellitusRisk FactorsInternal medicineDiabetes mellitusBlood plasmamedicineHumansAlbuminuriaMagnesiumTriglyceridesSerum ionized magnesiumAnalysis of VarianceNutrition and DieteticsWaist-Hip Ratiodiabetes mellitubusiness.industryType 2 Diabetes MellitusAlbuminuria; Diabetes mellitus; Metabolic syndrome; Plasma triglycerides; Serum ionized magnesium; Waist circumferenceMiddle Agedmedicine.diseaseMetabolic syndromeCross-Sectional StudiesEndocrinologyDiabetes Mellitus Type 2Waist circumferenceFemaleMetabolic syndromebusinessMagnesium DeficiencyBody mass index
researchProduct

Arterial stiffness, endothelial and cognitive function in subjects with type 2 diabetes in accordance with absence or presence of diabetic foot syndr…

2017

BACKGROUND: Endothelial dysfunction is an early marker of cardiovascular disease so endothelial and arterial stiffness indexes are good indicators of vascular health. We aimed to assess whether the presence of diabetic foot is associated with arterial stiffness and endothelial function impairment. METHODS: We studied 50 subjects with type 2 diabetes mellitus and diabetic foot syndrome (DFS) compared to 50 diabetic subjects without diabetic foot, and 53 patients without diabetes mellitus, by means of the mini mental state examination (MMSE) administered to evaluate cognitive performance. Carotid-femoral pulse wave velocity (PWV) and augmentation index (Aix) were also evaluated by Applanation…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismType 2 diabetes030204 cardiovascular system & hematologyVascular stiffness03 medical and health sciencesCognition0302 clinical medicineEndothelium functionDiabetes mellitusInternal medicineHumansMedicineEndothelial dysfunctionReactive hyperemiaPulse wave velocityAgedOriginal InvestigationFoot ulcerVascular healthbusiness.industryType 2 Diabetes MellitusMiddle Agedmedicine.diseaseDiabetic footDiabetic FootSurgeryCross-Sectional StudiesDiabetes Mellitus Type 2Pulsatile FlowArterial stiffnessCardiologyCognitive function; Endothelium function; Foot ulcer; Vascular health; Vascular stiffnessFemaleEndothelium VascularCognitive functionbusinessCardiology and Cardiovascular MedicineCardiovascular Diabetology
researchProduct

Effects of fluvastatin slow-release (XL 80 mg) versus simvastatin (20 mg) on the lipid triad in patients with type 2 diabetes.

2005

The lipid triad is the association of small, dense (sd) low-density lipoprotein (LDL), low high-density lipoprotein (HDL), and hypertriglyceridemia, all of which play a role in coronary artery disease in patients with type 2 diabetes. Although statins have demonstrated clear positive effects on cardiovascular morbidity/mortality in patients with diabetes and on single components of the lipid triad, it remains controversial whether they affect all components of the triad in these patients. Therefore, we performed a single-center, parallel-group, prospective, randomized, open-label, blinded-endpoint (PROBE)-type comparison of fluvastatin extended-release (XL) 80 mg (n=48) and simvastatin 20 m…

Malemedicine.medical_specialtySimvastatinIndolesHDLApolipoprotein BSmall dense LDLType 2 diabetesTriglycerideLDLFatty Acids MonounsaturatedFluvastatin XLInternal medicineDiabetes mellitusType 2 diabetes mellitusmedicineHumansPharmacology (medical)Prospective StudiesFluvastatinAgedHypertriglyceridemiabiologybusiness.industryAnticholesteremic AgentsApoA-IHypertriglyceridemianutritional and metabolic diseasesType 2 Diabetes MellitusGeneral MedicineMiddle Agedmedicine.diseaseLipoproteins LDLEndocrinologyDiabetes Mellitus Type 2SimvastatinDelayed-Action Preparationsbiology.proteinlipids (amino acids peptides and proteins)FemaleApoBbusinessLipoproteins HDLFluvastatinmedicine.drugLipoproteinAdvances in therapy
researchProduct

Early effects of empagliflozin on exercise tolerance in patients with heart failure: A pilot study

2018

BackgroundSodium-glucose linked transporter 2 inhibition recently emerged as a promising therapy for reducing the risk of heart failure (HF) in patients with type 2 diabetes mellitus (T2DM). However, there is a lack of data endorsing its role in symptomatic HF patients. We sought to evaluate the short-term effects of empagliflozin on maximal exercise capacity in these patients. HypothesisWe postulate tretament with empagliflozin may improve functional capacity in patients with T2DM and established HF. MethodsNineteen T2DM patients with symptomatic HF were prospectively included and underwent cardiopulmonary exercise testing before and 30days after initiation of empagliflozin therapy. A mixe…

Malemedicine.medical_specialtyTime FactorsClinical InvestigationsEmpagliflozinRenal functionPilot ProjectsWalk Test030204 cardiovascular system & hematology03 medical and health sciencesExercise Capacity0302 clinical medicineOxygen ConsumptionQuality of lifeGlucosidesInterquartile rangeInternal medicineEmpagliflozinmedicineHumansHypoglycemic Agents030212 general & internal medicineProspective StudiesBenzhydryl CompoundsProspective cohort studyAgedHeart FailureExercise Tolerancebusiness.industryRepeated measures designType 2 Diabetes MellitusGeneral MedicineRecovery of FunctionMiddle AgedEmpagliflozin Exercise Capacity Heart Failuremedicine.diseaseTreatment OutcomeDiabetes Mellitus Type 2Heart failureCardiologyQuality of LifeFemaleCardiology and Cardiovascular MedicinebusinessPulmonary Ventilation
researchProduct

Immunoinflammatory activation during the acute phase of lacunar and non-lacunar ischemic stroke: Association with time of onset and diabetic state

2006

Several studies have stressed the involvement of inflammation in the pathophysiology of acute brain ischemia, but the role of immunoinflammatory activation in diabetic stroke patients has not yet been fully evaluated. The aim of our study was to evaluate immunoinflammatory activation of acute phase of stroke in relation to time of symptoms onset, diabetic state and diagnostic subtype. We enrolled 60 patients (32 diabetics; 28 non- diabetics) with acute ischemic stroke and 123 subjects without acute ischemic stroke, and measured levels of IL-1β, TNF-α, IL-6, IL-10, E-selectin, P-selectin, sICAM-1, sVCAM-1, VWF, 24–72 h and 7–10 days after stroke onset; TPA, PAI-1 plasma levels at 24–72h. Ou…

Malemedicine.medical_specialtyTime FactorsImmunologyInflammationDiseaseBrain IschemiaBrain ischemia03 medical and health scienceschemistry.chemical_compound0302 clinical medicinestroke diabetes mellitusInternal medicineDiabetes mellitusPlasminogen Activator Inhibitor 1medicineDiabetes MellitusImmunology and AllergyHumanscardiovascular diseasesStrokeAgedPharmacologyAged 80 and overInflammationbusiness.industryTumor Necrosis Factor-alphaMiddle Agedmedicine.diseaseIntercellular Adhesion Molecule-1PathophysiologyStrokechemistry030220 oncology & carcinogenesisPlasminogen activator inhibitor-1Acute DiseaseCardiologyFemalemedicine.symptombusinessSelectin030215 immunologyInterleukin-1
researchProduct

Differences in clinical and biological characteristics and prevalence of chronic complications related to aging in patients with type 2 diabetes

2015

Type 2 diabetes mellitus (T2DM) is a chronic, highly prevalent disease that increases with age. Because of this, and due to its chronic complications, T2DM causes high human, social, and financial costs. In addition, the elderly population with T2DM has a marked clinical heterogeneity. Therefore, our main objective was to analyze the relationship of age with the clinical and biological manifestations of the disease and the prevalence of chronic complications in patients with T2DM.A cross-sectional study of a large population with T2DM (n=405) randomly selected from a Diabetes Unit and 2 health care centers (60%). The clinical, anthropometric, and biochemical variables of the subjects were c…

Malemedicine.medical_specialtyendocrine system diseasesCross-sectional studyBlood Pressure030209 endocrinology & metabolismDiseaseType 2 diabetes03 medical and health sciences0302 clinical medicineDiabetes mellitusInternal medicinePrevalencemedicineHumans030212 general & internal medicineTriglyceridesAgedMetabolic Syndromebusiness.industryAge Factorsnutritional and metabolic diseasesType 2 Diabetes MellitusMiddle Agedmedicine.diseaseSurgeryCross-Sectional StudiesDiabetes Mellitus Type 2FemaleWaist CircumferenceMetabolic syndromebusinessPolyneuropathyKidney diseaseEndocrinología y Nutrición (English Edition)
researchProduct

Plasma homocysteine levels are independently associated with the severity of peripheral polyneuropathy in type 2 diabetic subjects.

2012

Peripheral polyneuropathy (PN) is a frequent complication of diabetes. However, mechanisms underlying the development of PN are multifactorial and not well understood. Our aim was to examine the association of plasma homocysteine (Hcy) with the prevalence and grade of peripheral PN in patients with type 2 diabetes (T2DM). We studied a cohort of 196 subjects with T2DM classified according to the grade of PN (Neuropathy Disability Score, NDS). Subjects with the highest grade of PN were older and had significantly increased levels of creatinine, microalbuminuria, HbA1c, and plasma Hcy compared to the other two groups. The differences in plasma Hcy values were maintained after correcting for co…

Malemedicine.medical_specialtyendocrine system diseasesType 2 diabetesGastroenterologyCohort Studieschemistry.chemical_compoundDiabetic NeuropathiesInternal medicineDiabetes mellitusmedicineHumansProspective cohort studyHomocysteineAgedCreatininebusiness.industryGeneral NeuroscienceConfoundingnutritional and metabolic diseasesType 2 Diabetes MellitusMiddle Agedmedicine.diseaseEndocrinologychemistryDiabetes Mellitus Type 2CohortMicroalbuminuriaFemaleNeurology (clinical)businessJournal of the peripheral nervous system : JPNS
researchProduct